The cost-effectiveness of growth hormone replacement therapy (Genotropin®) in hypopituitary adults in Sweden

BACKGROUND: To evaluate the cost-effectiveness of growth hormone (GH) treatment (Genotropin®) compared with no GH treatment in adults with GH deficiency in a Swedish societal setting. METHODS: A Markov-type cost-utility simulation model was constructed and used to simulate, for men and women, morbid...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bolin, Kristian, Sandin, Rickard, Koltowska-Häggström, Maria, Loftus, Jane, Prütz, Christin, Jonsson, Björn
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2013
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3850881/
https://ncbi.nlm.nih.gov/pubmed/24079522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1478-7547-11-24
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares